Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04075773 · ClinicalTrials.gov registry record · NA

Brief Religious Alcohol Intervention

A NA study of Heavy Drinking, sponsored by University of Houston.

Completed
Registry status
NA
Development phase
203
Enrollment target
1
Study location

NCT04075773: Completed NA study of Heavy Drinking, sponsored by University of Houston.

NCT04075773 is a NA study of Heavy Drinking that has completed, run by University of Houston. The registered enrollment target is 203 participants, below the 327-participant average among 9 other Heavy Drinking trials with a reported enrollment target (38% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04075773, a NA study of Heavy Drinking, has completed, sponsored by University of Houston.

COMPLETED
Registry status
NA
Development phase
203 participants
Enrollment target
1
Study location

Study Summary

This study is a trial of a brief alcohol intervention, a brief expressive writing intervention that incorporates religious identity.

Primary Outcome

Participants report number of drinks consumed each day over the last month.

Conditions Studied

Interventions

  • BEHAVIORAL Expressive Writing

Study Locations (1)

Texas

  • University of Houston Psychology Department - Houston

Trial Details

FieldValue
Enrollment Target 203 participants
Start Date 2019-09-04
Est. Completion 2020-08-11
Phase NA
University of Houston

64 total trials

What the finished NCT04075773 record still lists

NCT04075773 is an interventional study that assigns participants to a tested intervention. The registered 203 participants enrollment target is mid-sized for trials with a published cap, below the 327-participant average among 9 other Heavy Drinking trials with a reported enrollment target (38% lower).

The record links to 1 condition, with Heavy Drinking appearing as the primary indexed condition, and to 1 intervention - of which Expressive Writing is the first listed.

NCT04075773 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT04075773 about?

NCT04075773 is a clinical study titled "Brief Religious Alcohol Intervention". This study is a trial of a brief alcohol intervention, a brief expressive writing intervention that incorporates religious identity.

What is the current status of trial NCT04075773?

This trial is currently completed. It is a NA study. The enrollment target is 203 participants. The study started on 2019-09-04. Estimated completion is 2020-08-11.

What conditions does trial NCT04075773 study?

This clinical trial studies the following conditions: Heavy Drinking.

What interventions are being tested in trial NCT04075773?

The interventions under investigation include: Expressive Writing (BEHAVIORAL).

Who is sponsoring clinical trial NCT04075773?

This trial is sponsored by University of Houston, which has 64 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04075773 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Heavy Drinking

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04075773's enrollment target sits among peer trials

203 7th of 9 higher than 3 of 9 other Heavy Drinking trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Heavy Drinking trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05652686 · 203 participants · Phase 1

    A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)

  • NCT06063122 · 203 participants · NA

    Development of a Therapeutic Device to Improve Speech Sound Differentiation in Preterm Infants

  • NCT07031245 · 203 participants · NA

    Evidence-Based Quality Improvement to Reduce VA Primary Care Burnout

  • NCT03481010 · 204 participants · NA

    Periacetabular Osteotomy With and Without Arthroscopic Management of Central Compartment Pathology

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04075773, the US trial registry maintained by the National Library of Medicine. NCT04075773 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.